(Q51054802)

27 March 2018

title

Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer. (English)

1 reference

27 March 2018

author name string

Zhongpeng Zhu

1

1 reference

27 March 2018

Baocheng Wang

2

1 reference

27 March 2018

Jingwang Bi

3

1 reference

27 March 2018

Cong Zhang

4

1 reference

27 March 2018

Yan Guo

5

1 reference

27 March 2018

Huili Chu

6

1 reference

27 March 2018

Xiuju Liang

7

1 reference

27 March 2018

Chen Zhong

8

1 reference

27 March 2018

Jun Wang

9

1 reference

27 March 2018

publication date

19 April 2013

1 reference

27 March 2018

published in

Tumor Biology

1 reference

27 March 2018

volume

34

1 reference

27 March 2018

issue

4

1 reference

27 March 2018

page(s)

2299-2308

1 reference

27 March 2018

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Changes to adjuvant systemic therapy in breast cancer: a decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Prognostic and predictive factors revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Prognostic and predictive factors in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Posttranscriptional regulation of cancer traits by HuR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Emerging roles of RNA and RNA-binding protein network in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

The RNA-binding protein HuR regulates the expression of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Expression of the embryonic lethal abnormal vision-like protein HuR in human mesothelioma: association with cyclooxygenase-2 and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Cytoplasmic expression of HuR is related to cyclooxygenase-2 expression in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

The direct activation of human multidrug resistance gene (MDR1) by anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Prognostic relevance of P-glycoprotein expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

ATP binding cassette transporters and drug resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Prognostic role of HuR in hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Role of RNA binding protein HuR in ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

MicroRNA-125a represses cell growth by targeting HuR in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

miR-519 suppresses tumor growth by reducing HuR levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Loss of repression of HuR translation by miR-16 may be responsible for the elevation of HuR in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Destabilization of ERBB2 transcripts by targeting 3' untranslated region messenger RNA associated HuR and histone deacetylase-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

The RNA-binding protein HuR promotes glioma growth and treatment resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Translational control of TOP2A influences doxorubicin efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Functional interplay between RNA-binding protein HuR and microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0774-3

Prognostic value of the human antigen R (HuR) in human breast cancer: high level predicts a favourable prognosis

21 January 2018

1 reference

12 December 2020

Cold-inducible RNA-binding protein contributes to human antigen R and cyclin E1 deregulation in breast cancer

1 reference

12 December 2020

Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9.

1 reference

12 December 2020

Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma.

1 reference

12 December 2020

Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer.

1 reference

12 December 2020

10.1007/S13277-013-0774-3

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018